PASG
Passage BIO, Inc.
- Latest sale
- $38k
- Jan 8 · Unusual
- Form 4 sales
- 26
- On record
- Form 144 notices
- 2
- Proposed sales
- Next unlock
- None
- No lockup ahead
Lockups
No lockup on record.
Sales by reason
Timeline
- 1 Form 4 saleNo planJan 8 2025
Sold 147,024 shares at $0.70 ($103k)
OrbiMed Capital GP VII LLC, 10% owner
No 10b5-1 planSold 2% of holdings ($5.2M position)7.3M shares left0.7x usual sizeFiling
- 2 Form 4 saleNo planJan 14 +6 days
Sold 223,219 shares at $0.64 ($142k)
Orbimed Advisors LLC, 10% owner
No 10b5-1 planSold 3.1% of holdings ($4.6M position)7M shares leftFiling
- 3 Form 4 saleNo planFeb 11 +28 days
Sold 3,183 shares at $0.53 ($2k)
Borthwick Kathleen, CFO
No 10b5-1 planSold 7.2% of holdings ($24k position)41,283 shares leftFiling
- 4 Form 4 saleNo planApr 17 +65 days
Sold 149,054 shares at $0.33 ($50k)
OrbiMed Capital GP VII LLC, 10% owner
No 10b5-1 planSold 2.1% of holdings ($2.3M position)6.9M shares left0.9x usual sizeFiling
- 5 Form 4 saleUnusualApr 24 +7 days
Sold 235,572 shares at $0.33 ($79k)
Orbimed Advisors LLC, 10% owner
No 10b5-1 planSold 3.4% of holdings ($2.3M position)6.7M shares left3.8x usual sizeFiling
- 6 Form 4 saleUnusualJun 26 +63 days
Sold 583,657 shares at $0.34 ($197k)
Orbimed Advisors LLC, 10% owner
No 10b5-1 planSold 8.8% of holdings ($2.2M position)6.1M shares left4.1x usual sizeFiling
- 7 Form 4 saleUnusualJan 8 +196 days
Sold 4,076 shares at $18.44 ($75k)
Chou William, PRESIDENT AND CEO
No 10b5-1 planSold 38.5% of holdings ($195k position)6,524 shares leftFirst sale on recordFiling
- 8 Form 4 saleUnusualJan 8 same day
Sold 2,062 shares at $18.44 ($38k)
Borthwick Kathleen, CFO
No 10b5-1 planSold 27.6% of holdings ($138k position)5,402 shares leftFiling
Every transaction
Loading transactions…
Sales, notices and lockups (28)
Export watchlist as CSV| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Jan 8, 2026 | Borthwick Kathleen | CFO | Form 4 sale | 2,062 | $38k | 27.6% | Unusual | SEC |
| Jan 8, 2026 | Chou William | PRESIDENT AND CEO | Form 4 sale | 4,076 | $75k | 38.5% | Unusual | SEC |
| Jun 26, 2025 | Orbimed Advisors LLC | 10% owner | Form 4 sale | 583,657 | $197k | 8.8% | Unusual | SEC |
| Apr 24, 2025 | Orbimed Advisors LLC | 10% owner | Form 4 sale | 235,572 | $79k | 3.4% | Unusual | SEC |
| Apr 17, 2025 | OrbiMed Capital GP VII LLC | 10% owner | Form 4 sale | 149,054 | $50k | 2.1% | No plan | SEC |
| Feb 11, 2025 | Borthwick Kathleen | CFO | Form 4 sale | 3,183 | $2k | 7.2% | No plan | SEC |
| Jan 14, 2025 | Orbimed Advisors LLC | 10% owner | Form 4 sale | 223,219 | $142k | 3.1% | No plan | SEC |
| Jan 8, 2025 | OrbiMed Capital GP VII LLC | 10% owner | Form 4 sale | 147,024 | $103k | 2.0% | No plan | SEC |
| Dec 20, 2024 | OrbiMed Capital GP VII LLC | 10% owner | Form 4 sale | 230,321 | $138k | 3.0% | No plan | SEC |
| Dec 11, 2024 | Orbimed Advisors LLC | 10% owner | Form 4 sale | 62,276 | $52k | 0.8% | No plan | SEC |
| Dec 6, 2024 | Orbimed Advisors LLC | 10% owner | Form 4 sale | 97,103 | $77k | 1.2% | No plan | SEC |
| Dec 4, 2024 | Orbimed Advisors LLC | Stockholder | Form 144 notice | 3M | $2.7M | Notice | SEC | |
| Dec 4, 2024 | Orbimed Capital LLC | Stockholder | Form 144 notice | 2M | $1.8M | Notice | SEC | |
| Sep 19, 2024 | Orbimed Advisors LLC | 10% owner | Form 4 sale | 39,300 | $28k | 0.5% | No plan | SEC |
| Sep 18, 2024 | OrbiMed Capital GP VII LLC | 10% owner | Form 4 sale | 200,131 | $147k | 2.5% | No plan | SEC |
| Feb 13, 2024 | Borthwick Kathleen | SVP, INTERIM CFO | Form 4 sale | 1,470 | $1k | 4.9% | No plan | SEC |
| Feb 13, 2024 | Forman Mark S | CHIEF MEDICAL OFFICER | Form 4 sale | 1,638 | $2k | 3.3% | No plan | SEC |
| Jan 2, 2024 | Forman Mark S | Chief Medical Officer | Form 4 sale | 15,813 | $14k | 25.9% | Unusual | SEC |
| Jan 2, 2024 | Borthwick Kathleen | SVP, Interim CFO | Form 4 sale | 10,672 | $10k | 29.2% | Unusual | SEC |
| Jan 2, 2024 | Cale Edgar B. | GC & Corporate Secretary | Form 4 sale | 15,813 | $14k | 25.6% | Unusual | SEC |
| Jul 28, 2023 | King Simona | Chief Financial Officer | Form 4 sale | 11,453 | $10k | 32.3% | Unusual | SEC |
| Jun 16, 2023 | Fotopoulos Alexandros | Chief Technical Officer | Form 4 sale | 4,052 | $4k | 12.4% | No plan | SEC |
| Apr 18, 2023 | King Simona | Chief Financial Officer | Form 4 sale | 2,053 | $2k | 50.0% | Unusual | SEC |
| Dec 1, 2022 | Kapadia Sandip | Director | Form 4 sale | 5,000 | $6k | 100.0% | Unusual | SEC |
| Nov 22, 2022 | Fotopoulos Alexandros | Chief Technical Officer | Form 4 sale | 3,720 | $5k | 15.5% | Plan not stated | SEC |
| Sep 19, 2022 | Toernsen Monika Maria | Chief Commercial Officer | Form 4 sale | 1,681 | $3k | 33.6% | Unusual | SEC |
| Mar 15, 2021 | Romano Gary | Chief Medical Officer | Form 4 sale | 10,000 | $211k | 100.0% | Unusual | SEC |
| Jan 20, 2021 | Quigley Jill M. | Chief Operating Officer | Form 4 sale | 1,300 | $39k | 0.4% | Plan not stated | SEC |